Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,446,000 | 5,813,000 | 8,860,000 | 9,421,000 | 8,437,000 |
| Marketable Securities | 700,000 | 609,000 | 625,000 | N/A | N/A |
| Receivables | 8,989,000 | 9,116,000 | 8,802,000 | 8,482,000 | 8,380,000 |
| Inventories | 7,097,000 | 7,227,000 | 6,867,000 | 6,954,000 | 6,901,000 |
| Other current assets | 2,833,000 | 10,286,000 | 3,054,000 | 2,609,000 | 2,820,000 |
| TOTAL | $32,065,000 | $33,051,000 | $28,208,000 | $27,466,000 | $26,538,000 |
| Non-Current Assets | |||||
| PPE Net | 15,957,000 | 16,677,000 | 16,464,000 | 16,263,000 | 16,206,000 |
| Investments And Advances | 10,359,000 | 10,521,000 | 17,613,000 | 28,692,000 | 27,926,000 |
| Intangibles | 74,610,000 | 66,250,000 | 61,747,000 | 62,551,000 | 63,079,000 |
| Other Non-Current Assets | 9,067,000 | 9,025,000 | 9,047,000 | 0 | 0 |
| TOTAL | $109,993,000 | $102,473,000 | $104,871,000 | $107,506,000 | $107,211,000 |
| Total Assets | $142,058,000 | $135,524,000 | $133,079,000 | $134,972,000 | $133,749,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,596,000 | 10,911,000 | 5,308,000 | 6,997,000 | 7,562,000 |
| Accounts payable and accrued liabilities | 5,486,000 | 4,994,000 | 5,169,000 | 4,685,000 | 4,691,000 |
| Other current liabilities | 11,161,000 | 10,563,000 | 11,203,000 | 13,697,000 | 13,893,000 |
| TOTAL | $27,943,000 | $28,223,000 | $23,403,000 | $25,379,000 | $26,146,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,760,000 | 23,199,000 | 23,224,000 | 23,163,000 | 22,999,000 |
| Other Non-Current Liabilities | 6,823,000 | 6,952,000 | 7,057,000 | 14,058,000 | 14,627,000 |
| TOTAL | $37,214,000 | $36,090,000 | $35,449,000 | $37,223,000 | $37,625,000 |
| Total Liabilities | $65,157,000 | $64,313,000 | $58,852,000 | $62,602,000 | $63,771,000 |
| Shareholders' Equity | |||||
| Common Shares | 944,000 | 969,000 | 969,000 | N/A | N/A |
| Retained earnings | 79,793,000 | 73,498,000 | 77,639,000 | N/A | N/A |
| Other shareholders' equity | -3,773,000 | -3,163,000 | -4,281,000 | 72,370,000 | 69,978,000 |
| TOTAL | $76,901,000 | $71,211,000 | $74,227,000 | $72,370,000 | $69,978,000 |
| Total Liabilities And Equity | $142,058,000 | $135,524,000 | $133,079,000 | $134,972,000 | $133,749,000 |